Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.

被引：8
|
作者：
Peixoto, Renata D'Alpino
Kumar, Aalok
Speers, Caroline
Renouf, Daniel John
Kennecke, Hagen F.
Lim, Howard John
Cheung, Winson Y.
Melosky, Barbara L.
Gill, Sharlene
机构：
[1] BC Canc Agcy, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.3561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3561
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of Delay in Adjuvant Oxaliplatin-Based Chemotherapy for Stage III Colon Cancer
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel
    Kennecke, Hagen F.
    Lim, Howard J.
    Cheung, Winson Y.
    Melosky, Barbara
    Gill, Sharlene
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (01) : 25 - 30
  • [2] Palliative oxaliplatin-based chemotherapy after exposure to oxaliplatin in the adjuvant setting for colon cancer.
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Gill, Sharlene
    Lim, Howard John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [3] Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
    Gallois, C.
    Taieb, J.
    Le Corre, D.
    Le Malicot, K.
    Tabernero, J.
    Mulot, C.
    Seitz, J-F.
    Aparicio, T.
    Folprecht, G.
    Lepage, C.
    Mini, E.
    Van Laethem, J-L.
    Emile, J. F.
    Laurent-Puig, P.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [4] Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy
    Gallois, Claire
    Taieb, Julien
    Le Corre, Delphine
    Le Malicot, Karine
    Tabernero, Josep
    Mulot, Claire
    Seitz, Jean-Francois
    Aparicio, Thomas
    Folprecht, Gunnar
    Lepage, Come
    Mini, Enrico
    Van Laethem, Jean-Luc
    Emile, Jean-Francois
    Laurent-Puig, Pierre
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4745 - 4753
  • [5] Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
    Eren, Tulay
    Pasaoglu, Lale
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [6] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [7] Cancer stem cells profile and clinical outcome in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy
    Giampieri, Riccardo
    Scartozzi, Mario
    Loretelli, Cristian
    Del Prete, Michela
    Faloppi, Luca
    Bianconi, Maristella
    Bittoni, Alessandro
    Mandolesi, Alessandra
    Bearzi, Italo
    Cascinu, Stefano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Oxaliplatin-Based Chemotherapy for Colon Cancer
    Bonetti, Andrea
    Furini, Lara
    [J]. PLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 271 - 284
  • [9] Palliative oxaliplatin-based chemotherapy after exposure to oxaliplatin in the adjuvant setting for colon cancer
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Lim, Howard John
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (05) : 487 - 491
  • [10] Reinduction of oxaliplatin-based chemotherapy after exposure to oxaliplatin in adjuvant setting for colorectal cancer.
    Beom, Seung-Hoon
    Ahn, Joong Bae
    Shin, Sang Joon
    Jung, Minkyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345